What are the indications and dosing guidelines for propranolol (beta-blocker)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Propranolol is indicated for various conditions, including stable, narrow-complex tachycardias, and its dosing guidelines are 0.5 to 1 mg over 1 minute, repeated up to a total dose of 0.1 mg/kg if required, as per the most recent guidelines 1.

Indications and Dosing Guidelines

The indications for propranolol include:

  • Stable, narrow-complex tachycardias
  • Control of ventricular rate in patients with atrial fibrillation or atrial flutter
  • Certain forms of polymorphic VT (associated with acute ischemia, familial LQTS, catecholaminergic) The dosing guidelines for propranolol are:
  • 0.5 to 1 mg over 1 minute, repeated up to a total dose of 0.1 mg/kg if required

Important Considerations

When using propranolol, it is essential to consider the following:

  • Avoid using propranolol in patients with asthma, obstructive airway disease, decompensated heart failure, and pre-excited atrial fibrillation or flutter
  • Propranolol can cause hypotension, bradycardia, and precipitation of heart failure
  • The medication works by blocking both beta-1 receptors (affecting heart rate and contractility) and beta-2 receptors (affecting bronchial and vascular smooth muscle)

Additional Information

According to the American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy 1, propranolol has been used in the medical management of HCM, with doses ranging from 40-160 mg twice daily, and up to 480 mg per day in some cases. However, the most recent guidelines from the American Heart Association 1 should be followed for the management of tachycardias.

From the FDA Drug Label

DOSAGE AND ADMINISTRATION General: Propranolol hydrochloride extended-release capsules provide propranolol hydrochloride in a sustained-release capsule for administration once daily. Hypertension: The usual initial dosage is 80 mg propranolol hydrochloride extended-release capsules once daily, whether used alone or added to a diuretic. Angina Pectoris: Starting with 80 mg propranolol hydrochloride extended-release capsules once daily, dosage should be gradually increased at three- to seven-day intervals until optimal response is obtained Migraine: The initial oral dose is 80 mg propranolol hydrochloride extended-release capsules once daily. Hypertrophic Subaortic Stenosis: The usual dosage is 80 to 160 mg propranolol hydrochloride extended-release capsules once daily. INDICATIONS AND USAGE Hypertension: Propranolol hydrochloride extended-release capsules are indicated in the management of hypertension. Angina Pectoris Due to Coronary Atherosclerosis: Propranolol hydrochloride extended-release capsules are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. Migraine: Propranolol hydrochloride extended-release capsules are indicated for the prophylaxis of common migraine headache Hypertrophic Subaortic Stenosis: Propranolol hydrochloride extended-release capsules improve NYHA functional class in symptomatic patients with hypertrophic subaortic stenosis.

The indications for propranolol are:

  • Hypertension
  • Angina Pectoris
  • Migraine
  • Hypertrophic Subaortic Stenosis The dosing guidelines for propranolol are:
  • Hypertension: 80-640 mg once daily
  • Angina Pectoris: 80-320 mg once daily
  • Migraine: 80-240 mg once daily
  • Hypertrophic Subaortic Stenosis: 80-160 mg once daily 2 2

From the Research

Indications for Propranolol

  • Propranolol is used to control hypertension, pheochromocytoma, myocardial infarction, cardiac arrhythmias, angina pectoris, and hypertrophic cardiomyopathy 3
  • It is also used to control symptoms of sympathetic overactivity in the management of hyperthyroidism, anxiety disorders, and tremor 3
  • Other indications cover the prophylaxis of migraine and of upper gastrointestinal bleeding in patients with portal hypertension 3
  • Propranolol may be useful in hypertension patients having a hyperkinetic circulation (palpitations, tachycardia, hypertension, and anxiety), migraine headache, and essential tremor 4

Dosing Guidelines for Propranolol

  • The dosing guidelines for propranolol vary depending on the indication and patient population 3
  • For migraine prophylaxis, propranolol is typically started at a low dose and titrated up to an effective dose, with a common dose range of 20-60 mg every 6 hours 5, 6
  • In critically ill patients receiving mechanical ventilation, propranolol has been used at a dose of 20-60 mg every 6 hours, titrated to effect 6

Pharmacological Properties of Propranolol

  • Propranolol is a noncardioselective β-blocker with membrane-stabilizing properties, but it does not have intrinsic sympathomimetic activity 3
  • β-Blockers, including propranolol, are highly heterogeneous with respect to various pharmacologic properties, such as degree of intrinsic sympathomimetic activity, membrane stabilizing activity, β1 selectivity, α1-adrenergic blocking effects, tissue solubility, routes of systemic elimination, potencies and duration of action 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Propranolol.

Profiles of drug substances, excipients, and related methodology, 2017

Research

Beta-Adrenergic Receptor Blockers in Hypertension: Alive and Well.

Progress in cardiovascular diseases, 2016

Research

Propranolol for migraine prophylaxis.

The Cochrane database of systematic reviews, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.